ESPB vs SPSIP for Postoperative Analgesia After CABG

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-85
SponsorKutahya Health Sciences University

About this trial

This prospective, randomized, active-controlled, double-blind, parallel-group study compares the postoperative analgesic efficacy and safety of ultrasound-guided bilateral Erector Spinae Plane Block (ESPB) versus bilateral Serratus Posterior Superior Intercostal Plane Block (SPSIPB) in adult patients (45-85 years, ASA I-III) undergoing elective coronary artery bypass graft surgery. The primary outcome is postoperative pain intensity assessed by Numeric Rating Scale (NRS) at 2, 4, 8, 16, 24, and 48 hours after surgery. Secondary outcomes include intraoperative fentanyl/remifentanil consumption, postoperative morphine consumption, patient-controlled analgesia (PCA) demand/delivery parameters (if PCA is used), need for rescue analgesics, extubation and mobilization times, peak inspiratory flow measured by incentive spirometry at predefined time points, ICU and hospital length of stay, recovery quality (QoR-15 at 0, 24, and 48 hours), mortality, and block-related adverse events.

Eligibility criteria

Qualifiers

Age 45-85 years

Scheduled for elective coronary artery bypass graft (CABG) surgery

American Society of Anesthesiologists (ASA) I-II-III

Patients who provide written informed consent and agree to participate in the study

Disqualifiers

Emergency cases

ASA IV-V

Known allergy to local anesthetics

Coagulopathy (platelet count <100,000/mm³, INR >1.5, aPTT >1.5× normal)

Trial design

Treatments tested in this trial

  • Ultrasound-guided Erector Spinae Plane Block (ESPB)
  • Ultrasound-guided Serratus Posterior Superior Intercostal Plane Block (SPSIPB)

Treatment groups

64 Participants
are divided into 2 treatment groups